The 12-month price targets, analyzed by analysts, offer insights with an average target of $140.33, a high estimate of $170.00, and a low estimate of $105.00. This upward trend is apparent, with the ...

The stock of the day on Tuesday was ProKidney Corp.'s, as it was both the biggest gainer and the most actively traded on major U.S. exchanges, after the biotechnology company's diabetes treatment ...